BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 9311991)

  • 1. Neoplastic transformation of rat thyroid cells requires the junB and fra-1 gene induction which is dependent on the HMGI-C gene product.
    Vallone D; Battista S; Pierantoni GM; Fedele M; Casalino L; Santoro M; Viglietto G; Fusco A; Verde P
    EMBO J; 1997 Sep; 16(17):5310-21. PubMed ID: 9311991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increase in AP-1 activity is a general event in thyroid cell transformation in vitro and in vivo.
    Battista S; de Nigris F; Fedele M; Chiappetta G; Scala S; Vallone D; Pierantoni GM; Mega T; Santoro M; Viglietto G; Verde P; Fusco A
    Oncogene; 1998 Jul; 17(3):377-85. PubMed ID: 9690519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presence of distinct AP-1 dimers in normal and transformed rat hepatocytes under basal conditions and after epidermal growth factor stimulation.
    Nadori F; Lardeux B; Rahmani M; Bringuier A; Durand-Schneider AM; Bernuau D
    Hepatology; 1997 Dec; 26(6):1477-83. PubMed ID: 9397987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fra-1 promotes growth and survival in RAS-transformed thyroid cells by controlling cyclin A transcription.
    Casalino L; Bakiri L; Talotta F; Weitzman JB; Fusco A; Yaniv M; Verde P
    EMBO J; 2007 Apr; 26(7):1878-90. PubMed ID: 17347653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High levels of phosphorylated c-Jun, Fra-1, Fra-2 and ATF-2 proteins correlate with malignant phenotypes in the multistage mouse skin carcinogenesis model.
    Zoumpourlis V; Papassava P; Linardopoulos S; Gillespie D; Balmain A; Pintzas A
    Oncogene; 2000 Aug; 19(35):4011-21. PubMed ID: 10962557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
    Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
    Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesothelial cell transformation requires increased AP-1 binding activity and ERK-dependent Fra-1 expression.
    Ramos-Nino ME; Timblin CR; Mossman BT
    Cancer Res; 2002 Nov; 62(21):6065-9. PubMed ID: 12414630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HMGI(Y) and HMGI-C genes are expressed in neuroblastoma cell lines and tumors and affect retinoic acid responsiveness.
    Giannini G; Di Marcotullio L; Ristori E; Zani M; Crescenzi M; Scarpa S; Piaggio G; Vacca A; Peverali FA; Diana F; Screpanti I; Frati L; Gulino A
    Cancer Res; 1999 May; 59(10):2484-92. PubMed ID: 10344762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pdcd4 suppresses tumor phenotype in JB6 cells by inhibiting AP-1 transactivation.
    Yang HS; Knies JL; Stark C; Colburn NH
    Oncogene; 2003 Jun; 22(24):3712-20. PubMed ID: 12802278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroid cell transformation requires the expression of the HMGA1 proteins.
    Berlingieri MT; Pierantoni GM; Giancotti V; Santoro M; Fusco A
    Oncogene; 2002 May; 21(19):2971-80. PubMed ID: 12082527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure and transcriptional regulation of BKJ, a novel AP-1 target gene activated during jun- or fos-induced fibroblast transformation.
    Hartl M; Bister K
    Oncogene; 1998 Dec; 17(22):2901-13. PubMed ID: 9879996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conversion of HPV 18 positive non-tumorigenic HeLa-fibroblast hybrids to invasive growth involves loss of TNF-alpha mediated repression of viral transcription and modification of the AP-1 transcription complex.
    Soto U; Das BC; Lengert M; Finzer P; zur Hausen H; Rösl F
    Oncogene; 1999 May; 18(21):3187-98. PubMed ID: 10359524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AP-1 transrepressing retinoic acid does not deplete coactivators or AP-1 monomers but may target specific Jun or Fos containing dimers.
    Suzukawa K; Colburn NH
    Oncogene; 2002 Mar; 21(14):2181-90. PubMed ID: 11948401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transition from SCLC to NSCLC phenotype is accompanied by an increased TRE-binding activity and recruitment of specific AP-1 proteins.
    Risse-Hackl G; Adamkiewicz J; Wimmel A; Schuermann M
    Oncogene; 1998 Jun; 16(23):3057-68. PubMed ID: 9662339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and distribution of AP-1 transcription factors in the porcine ovary.
    Rusovici R; LaVoie HA
    Biol Reprod; 2003 Jul; 69(1):64-74. PubMed ID: 12606371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional induction of cyclooxygenase-2 gene by okadaic acid inhibition of phosphatase activity in human chondrocytes: co-stimulation of AP-1 and CRE nuclear binding proteins.
    Miller C; Zhang M; He Y; Zhao J; Pelletier JP; Martel-Pelletier J; Di Battista JA
    J Cell Biochem; 1998 Jun; 69(4):392-413. PubMed ID: 9620167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.
    Zerbini LF; Wang Y; Cho JY; Libermann TA
    Cancer Res; 2003 May; 63(9):2206-15. PubMed ID: 12727841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fos-related antigen 1 modulates malignant features of glioma cells.
    Debinski W; Gibo DM
    Mol Cancer Res; 2005 Apr; 3(4):237-49. PubMed ID: 15831677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human T-cell leukemia virus type 1 tax protein activates transcription through AP-1 site by inducing DNA binding activity in T cells.
    Iwai K; Mori N; Oie M; Yamamoto N; Fujii M
    Virology; 2001 Jan; 279(1):38-46. PubMed ID: 11145887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antisense targeting of c-fos transcripts inhibits serum- and TGF-beta 1-stimulated PAI-1 gene expression and directed motility in renal epithelial cells.
    Kutz SM; Providence KM; Higgins PJ
    Cell Motil Cytoskeleton; 2001 Mar; 48(3):163-74. PubMed ID: 11223948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.